Kotak Mahindra sold 69.48 lakh equity shares or 2.81% stake held in Sequent Scientific. Post sale, Kotak Mahindra Investments reduced its stake to 89.15 lakh equity shares or 3.61% stake from 1.58 crore equity shares or 6.43% stake held in the pharmaceutical company. The disclosure was made on Saturday, 21 December 2019.

Shares of Sequent Scientific gained 1.67% to Rs 73.05 on BSE.

On 16 December 2019, Kotak Mahindra Investments raised its stake in the company by 2.81% to 6.42% stake. Kotak Mahindra lnvestments holds equity stake in Sequent Scientific as margin for extending loan facility. The disclosure was made after trading hours on Wednesday, 18 December 2019.

The S&P BSE Sensex was down 46.18 points or 0.11% at 41,635.36.

On a consolidated basis, Sequent Scientific's net profit soared 39.8% to Rs 21.29 crore on 12.1% increase in net sales to Rs 284.22 crore in Q2 September 2019 over Q2 September 2018.

Sequent Scientific is a pharmaceutical company. Its segments include pharmaceuticals, speciality chemicals and analytical services. It focuses on products for livestock, poultry and companion animals. It also offers laboratory and technical support services.